Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection
- PMID: 8743084
- DOI: 10.1089/aid.1996.12.585
Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection
Abstract
Some individuals in well-defined cohorts have now been infected with HIV-1 for well over a decade and yet remain clinically asymptomatic with normal CD4 counts. To determine immunologic and virologic parameters in these individuals, we examined 10 persons from the San Francisco City Clinic with firmly documented infection of 11-15 years duration who had maintained stable CD4 counts above 500 cells/microliters. Our results indicate that long-term nonprogressors are a heterogeneous group with respect to viral load and HIV-1-specific immune responses, and that progression can occur even after 15 years of stable infection. However, in a subset of persons with the lowest viral loads and persistent nonprogressive infection, we detected strong CTL responses, whereas neutralizing antibody studies revealed weak to undetectable titers against a panel of 10 primary isolates. This study demonstrates that a vigorous in vivo activated HIV-1-specific CTL response can be part of the host immune response in stable nonprogressive HIV-1 infection, and that circulating activated CTL can be detected in the setting of an extremely low viral load. These results also indicate that long-term nonprogressing HIV-1 infection does not require the presence of broadly cross-reactive neutralizing antibodies.
Similar articles
-
Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.J Immunol. 1996 Apr 1;156(7):2616-23. J Immunol. 1996. PMID: 8786327
-
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.N Engl J Med. 1995 Jan 26;332(4):209-16. doi: 10.1056/NEJM199501263320402. N Engl J Med. 1995. PMID: 7808486
-
Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors.J Infect Dis. 1999 May;179(5):1264-7. doi: 10.1086/314711. J Infect Dis. 1999. PMID: 10191234
-
Anti-HIV adaptive immunity: determinants for viral persistence.Rev Med Virol. 2008 Sep-Oct;18(5):293-303. doi: 10.1002/rmv.577. Rev Med Virol. 2008. PMID: 18416450 Review.
-
The role of CD8+ T-cell response in HIV infection.AIDS Rev. 2004 Apr-Jun;6(2):79-88. AIDS Rev. 2004. PMID: 15332430 Review.
Cited by
-
Energy demanding RNA and protein metabolism drive dysfunctionality of HIV-specific T cell changes during chronic HIV infection.PLoS One. 2024 Oct 2;19(10):e0298472. doi: 10.1371/journal.pone.0298472. eCollection 2024. PLoS One. 2024. PMID: 39356699 Free PMC article.
-
Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load.J Virol. 2004 Apr;78(7):3233-43. doi: 10.1128/jvi.78.7.3233-3243.2004. J Virol. 2004. PMID: 15016844 Free PMC article.
-
Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-gamma-producing memory CD4+ T cells.Clin Exp Immunol. 2002 Sep;129(3):429-37. doi: 10.1046/j.1365-2249.2002.01934.x. Clin Exp Immunol. 2002. PMID: 12197883 Free PMC article.
-
Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma.J Virol. 2003 Nov;77(22):12105-12. doi: 10.1128/jvi.77.22.12105-12112.2003. J Virol. 2003. PMID: 14581547 Free PMC article.
-
Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1.J Virol. 1998 Dec;72(12):9855-64. doi: 10.1128/JVI.72.12.9855-9864.1998. J Virol. 1998. PMID: 9811721 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials